In the competitive landscape of health and fitness technology, securing investment can be a game-changer for innovative startups. Applied Monitoring, a trailblazer in this space based in Sunderland, UK, has recently made headlines by raising an additional £500K in funding, led by Mercia Ventures’ North East Venture Fund. This latest influx not only underscores the company’s potential but also highlights the growing interest among investors in cutting-edge solutions that enhance athletic performance.
Founded in 2018 by Jon Dixon and Rob Connell, Applied Monitoring has developed a groundbreaking, non-invasive method for monitoring lactate levels in blood.
This technology is pivotal for athletes, as it helps in detecting peak exertion levels and tailoring training regimens accordingly. After successful trials at Durham University, the startup has taken a significant leap forward by partnering with a microchip producer to create a compact device that could be seamlessly embedded in an armband, syncing effortlessly with a smartwatch. Such innovations are not only appealing to fitness enthusiasts but also significantly increase the company’s attractiveness to potential investors.
With this recent £500K funding round, Applied Monitoring has successfully raised over £1 million to date, largely owing to the support of Mercia and the NEVF since its initial funding in 2022. The capital injection is set to fuel their operational expansion and development initiatives, establishing a robust platform for future growth. For startup founders seeking investment in health tech, Applied Monitoring serves as an inspiring example of how transformative ideas, backed by the right funding, can revolutionize industries and enhance human performance.
Click here for a full list of 6,908+ startup investors in the UK